Diligence memo · auto-generated · as of July 3, 2026
Ent Biotech Solutions, Inc.
Ent Biotech Solutions, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Ent Biotech Solutions, Inc. operates in Other Health Care, based in GROSSE POINTE FARMS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ent Biotech Solutions, Inc. has raised $2.5M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.1M on 2015-03-16.
Most recent recorded round closed around 2015-03-16.
Valuation (modeled)modeled
Provath models Ent Biotech Solutions, Inc. at approximately $27M (range $931K–$214M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.63× the median modeled value of Seed Other Health Care companies in 2013–2015 (251 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 11.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 51% of Other Health Care peers (5377 compared).
Modeled value ranks above 55% of those peers.
Closest niche peers: RightCare Solutions, Inc., Vios Medical, Inc., HealthEdge Investors DD Holdings, LLC, Center at Northridge, LLC, Fresenius Medical Care NKDHC, LLC.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.